How Much Weight Should I Expect to Lose on Ozempic?

Last reviewed: June 8, 2026

Last updated: June 8, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide—the active compound in medications like Ozempic—reduced body weight by an average of 15% in the SUSTAIN-1 trial and up to 22% in higher-dose studies over approximately one year. However, the amount of weight you lose depends on your starting point, genetic response profile, dose escalation, lifestyle choices, and how consistently you use the medication.

Typical Semaglutide Weight Loss Results in Clinical Trials

The landmark SUSTAIN-1 trial showed that participants receiving semaglutide 1.0 mg weekly lost an average of 4.6 kg (10 lbs) over 30 weeks, with continued weight reduction reaching approximately 15% body weight loss by week 68. In the SUSTAIN-7 trial, patients on the higher 2.4 mg dose achieved mean weight reductions of 20–22% compared to baseline. These results represent significant changes over a 12–16 month period, though some individuals saw losses as high as 25–30% of their starting weight.

Weight loss typically follows a predictable pattern: most visible progress occurs in months 2–6 after dose stabilization, with continued but slower loss through month 12 and beyond. A typical starting semaglutide dose of 0.25 mg weekly produces modest initial effects, which increase as the dose escalates to 0.5 mg, then 1.0 mg, and potentially to 1.7 mg or 2.4 mg if prescribed. Your individual timeline and total loss will reflect how your body metabolizes the medication and adapts to appetite suppression.

Factors That Influence Your Personal Weight Loss Outcome

Starting body weight, age, sex, baseline metabolic rate, and insulin sensitivity all shape how much weight you ultimately lose on semaglutide. Individuals with higher starting weights or greater insulin resistance often experience larger absolute weight reductions (in pounds or kilograms), though percentage loss may be similar across groups. Adherence—consistent weekly injections without missed doses—is one of the strongest predictors of success, since the medication's appetite-suppressing effects diminish if dosing is interrupted.

Genetic variations in the GLP-1 receptor pathway, the GIPR pathway, and metabolic genes like FTO and MC4R influence how effectively semaglutide suppresses hunger and how your body distributes fat loss. PlexusDx's Precision Peptide Genetic Test maps 14 pathways and identifies variants in your GLP-1R, GIPR, FTO, and MC4R genes to predict whether you are a robust responder, moderate responder, or require personalized protocol adjustments. Individuals carrying certain genetic variants in these pathways may experience faster initial weight loss or may respond better to combination approaches than to semaglutide alone.

Realistic Monthly Weight Loss Expectations

During the first month of semaglutide, many patients lose 2–4 lbs as the dose is still low and the body is adjusting to the medication. Months 2–4, when doses reach 0.5–1.0 mg, typically show the steepest weight loss curve—averaging 2–4 lbs per week or 8–16 lbs per month for some individuals. By months 5–12, as your body adapts and you approach your biological set point influenced by your genetic makeup, weight loss often slows to 1–2 lbs per week, though this varies considerably.

Plateau periods—weeks or months with no change on the scale—are normal and do not signal medication failure. Many patients experience plateaus lasting 2–4 weeks, then resume weight loss after the body recalibrates. Dose escalation or dietary adjustments can restart momentum. Total weight loss by 12 months ranges from 10–30% of starting body weight depending on adherence, genetic response profile, and lifestyle factors such as exercise and nutrition quality.

How PlexusDx Personalizes Your Semaglutide Treatment Plan

PlexusDx Compounded Semaglutide Injection starts at $149 per month, with no flat per-compound pricing increases—your dose may need to go up, but your price won't. All medications are manufactured by licensed 503A compounding pharmacies and are available in all 50 states without insurance requirements. After your first month of treatment, PlexusDx offers the Precision Peptide Genetic Test for $99, which identifies genetic markers in your GLP-1R, GIPR, FTO, and MC4R genes to predict your response class and optimize your treatment protocol.

By understanding your peptide pathway genetics, PlexusDx clinicians can recommend whether you are a candidate for semaglutide monotherapy, combination therapy (such as GLP-Squared, which combines semaglutide and tirzepatide), or the microdose GLP-1 protocol. Genetic insights help explain why some patients achieve 25%+ weight loss while others plateau at 10–15%, empowering you to make informed decisions and adjust treatment earlier. HSA and FSA funds are eligible, making precision-guided semaglutide therapy accessible and affordable.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

How much weight do most people lose in the first month on semaglutide?

Most patients lose 2–4 lbs in the first month because the starting dose (0.25 mg) is low and the body is acclimating. Weight loss accelerates in months 2–4 as doses increase to 0.5–1.0 mg, when many people report losses of 2–4 lbs per week. PlexusDx tracks your progress and adjusts dosing to optimize results over your full treatment timeline.

Is 15% weight loss typical, or can I expect more?

The SUSTAIN-1 clinical trial reported an average of 15% body weight loss over 68 weeks, while higher-dose studies (2.4 mg) showed 20–22% average losses. Individual results range from 10–30% depending on genetics, adherence, starting weight, and lifestyle. PlexusDx's Precision Peptide Genetic Test can help predict whether you're likely to be a high responder based on your GLP-1R and GIPR variants.

What is the cost to start semaglutide at PlexusDx?

PlexusDx Compounded Semaglutide Injection starts at $149 per month, with no increase in price as your dose increases. All medications come from licensed 503A compounding pharmacies, are available nationwide without insurance, and are HSA/FSA eligible. You can add the Precision Peptide Genetic Test for $99 after your first month to personalize your protocol.

Why do some people lose more weight than others on semaglutide?

Genetic variation in GLP-1R, GIPR, FTO, and MC4R pathways significantly influences appetite suppression strength and metabolic response. Adherence, diet quality, physical activity, starting weight, age, and insulin sensitivity also play major roles. PlexusDx's genetic testing identifies these variants to explain individual differences and guide treatment optimization for your unique biology.

Can genetic testing help predict my semaglutide results before I start?

Yes. PlexusDx's Precision Peptide Genetic Test ($99 after first month) analyzes 14 pathways and 49 peptides, including your GLP-1R rs6923761 and GIPR rs1800437 variants, to classify you as a robust, moderate, or adapted responder. This insight helps clinicians recommend optimal dosing strategy and whether combination therapy or alternative protocols might deliver better outcomes for your genetic profile.

Related Reading

• Ozempic For Losing Weight
• Ozempic For Weight Loss 2
• Average Weight Loss On Ozempic
• Weight Loss Drugs Like Ozempic

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.